385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797630912869957632 |
|---|---|
| author | Steven A Rosenberg Stephanie Goff Frank Lowery Nivedita Ratnam Hyunmi Halas |
| author_facet | Steven A Rosenberg Stephanie Goff Frank Lowery Nivedita Ratnam Hyunmi Halas |
| author_sort | Steven A Rosenberg |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:13:35Z |
| format | Article |
| id | doaj.art-85ff5b60c39b4b20b5737e258998f54b |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:13:35Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-85ff5b60c39b4b20b5737e258998f54b2023-11-11T07:50:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0385385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic mannerSteven A Rosenberg0Stephanie Goff1Frank Lowery2Nivedita Ratnam3Hyunmi Halas4Surgery Branch, National Cancer Institute, Bethesda, Maryland, USANational Cancer Institute, National Institutes of Health, Bethesda, MD, USANational Cancer Institute, Bethesda, MD, United StatesNational Cancer Institute, National Institutes of Health, Bethesda, MD, USANational Cancer Institute, National Institutes of Health, Bethesda, MD, USA |
| spellingShingle | Steven A Rosenberg Stephanie Goff Frank Lowery Nivedita Ratnam Hyunmi Halas 385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner Journal for ImmunoTherapy of Cancer |
| title | 385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner |
| title_full | 385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner |
| title_fullStr | 385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner |
| title_full_unstemmed | 385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner |
| title_short | 385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner |
| title_sort | 385 selection of cd8 cd103 cd31 tumor infiltrating lymphocytes til from bulk cultures enriches tumor specific reactivity in a patient agnostic manner |
| work_keys_str_mv | AT stevenarosenberg 385selectionofcd8cd103cd31tumorinfiltratinglymphocytestilfrombulkculturesenrichestumorspecificreactivityinapatientagnosticmanner AT stephaniegoff 385selectionofcd8cd103cd31tumorinfiltratinglymphocytestilfrombulkculturesenrichestumorspecificreactivityinapatientagnosticmanner AT franklowery 385selectionofcd8cd103cd31tumorinfiltratinglymphocytestilfrombulkculturesenrichestumorspecificreactivityinapatientagnosticmanner AT niveditaratnam 385selectionofcd8cd103cd31tumorinfiltratinglymphocytestilfrombulkculturesenrichestumorspecificreactivityinapatientagnosticmanner AT hyunmihalas 385selectionofcd8cd103cd31tumorinfiltratinglymphocytestilfrombulkculturesenrichestumorspecificreactivityinapatientagnosticmanner |